Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

In silico testing of the toxicity for some anticancer herbal compounds (CROSBI ID 656980)

Prilog sa skupa u zborniku | izvorni znanstveni rad | međunarodna recenzija

Tomić, Draško ; Puškarić, Miroslav ; Car, Zlatan In silico testing of the toxicity for some anticancer herbal compounds // Proceedings of International Conference on Innovative Technologies / Pepelnjak Tomaž ; Car Zlatan ; Kudláček Jan (ur.). Jaromer: Tehnički fakultet Sveučilišta u Rijeci, 2017. str. 217-220

Podaci o odgovornosti

Tomić, Draško ; Puškarić, Miroslav ; Car, Zlatan

engleski

In silico testing of the toxicity for some anticancer herbal compounds

Herbal based anticancer drugs are known for their relative low toxicity compared to standard chemoterapeutics. Besides, the developing of cancer resistance to herbal based drug is less frequent, due to the complex drug structure. However, as each drug, these drugs can also express the considerable and in some cases even fatal dose dependent level of toxicity, when applied in to high doses. Another cause of toxicity can be a too long period of therapy, due to the successive cumulation of a drug in the tissues. Besides, the toxicity can be expressed as genotoxicity, cardiotoxicity, dermal toxicity, hepatotoxicity, nephrotoxicity and receptor- mediated toxicity, or any combination of them. Therefore, and especially in cases when standard chemoterapeutics are no choice, the application of herbal based anticancer drugs is the only choice. As clinical trials for these class of drugs are relative rare, their toxicity is mostly unknown. For this, we performed in silico testing for several herbal anticancer compounds, and where available, compared the results with toxicity data gathered from in vivo experiments. Our results show in silico testing of toxicity of anticancer herbal compounds is of the outmost importance in cased when the standard therapy fails, in vivo experimental data are missing or incomplete, and the quick alternative therapy is the only way to aleviate cancer related clinical simptoms.

anticancer herval compounds ; in silico testing of toxicity ; dose dependent level of toxicity ; successive cumulation of drug in tissues

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

217-220.

2017.

objavljeno

Podaci o matičnoj publikaciji

Proceedings of International Conference on Innovative Technologies

Pepelnjak Tomaž ; Car Zlatan ; Kudláček Jan

Jaromer: Tehnički fakultet Sveučilišta u Rijeci

0184-9069

Podaci o skupu

IN-TECH 2017 International Conference on Innovative Technologies

predavanje

11.09.2017-13.09.2017

Ljubljana, Slovenija

Povezanost rada

Računarstvo, Biotehnologija, Informacijske i komunikacijske znanosti